x

Turning science into breakthroughs

An alliance to catalyze the development of novel therapeutics

On June 5th, 2019, Columbia University and Deerfield Management announced the creation of a major research and development alliance. The collaboration is intended to advance the translation of biomedical discoveries into transformative treatments for improved quality of life and cures for disease.

Through a newly launched company called Hudson Heights Innovations, up to $130 million of initial funding will be made available to back the initiative over 10 years by Deerfield and its partners. In addition, Deerfield will provide development expertise in support of innovative drug research across a span of high-need therapeutic areas, as well as those targeting patients who suffer from hard-to-treat and rare diseases.

Deerfield is a healthcare investment management firm committed to advancing healthcare through investment, information and philanthropy. For more information, please visit www.deerfield.com.

Among the world’s leading research universities, Columbia University in the City of New York continually seeks to advance the frontiers of scholarship and foster a campus community deeply engaged in understanding and confronting the complex issues of our time through teaching, research, patient care and public service.

Timeline for Proposal Submissions

Proposal Sourcing

Principal Investigators are invited to submit proposals.

Scientific Review

Your proposal will be reviewed by members of our scientific team.

Full Proposal

If your idea is selected for further evaluation, you will be invited to submit a full proposal.

Investment Evaluated

Your proposal will be carefully evaluated for funding by Deerfield’s investment team.

Have more specific questions?

Find answers to commonly asked questions or submit a specific request.